Unternehmen G9pharma co., LTD
Aktien
A078650
KR7078650009
A078650
Medizinische Versorgung
Kurzporträt
Mitarbeiterzahl: 7
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Taek-Hwe Jang
CEO | Chief Executive Officer | 43 | - |
Jae-Gyu Park
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Dong-Gwon Kim
AUD | Comptroller/Controller/Auditor | 71 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jae-Eon Jung
BRD | Director/Board Member | 65 | - |
Seok-Hwan Choi
BRD | Director/Board Member | 53 | - |
Taek-Hwe Jang
CEO | Chief Executive Officer | 43 | - |
Sung-Kyu Kim
BRD | Director/Board Member | 69 | - |
Su-Dong Kim
BRD | Director/Board Member | 58 | - |
Ju-Hee Kim
BRD | Director/Board Member | 53 | - |
Dae-Hee Shin
BRD | Director/Board Member | 66 | - |
Na Lee
BRD | Director/Board Member | 43 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 4 078 777 | 3 614 663 ( 88,62 %) | 0 | 88,62 % |
Unternehmenskontakt
![Straße G9pharma co., LTD(A078650)](https://cdn.zonebourse.com/static/address/20706176.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+11.12% | 98.2 Mrd. | |
+22.58% | 44.14 Mrd. | |
-7.73% | 17.38 Mrd. | |
-30.56% | 1.94 Mrd. | |
+20.81% | 1.15 Mrd. | |
+75.07% | 675 Mio. | |
-9.93% | 651 Mio. | |
-44.04% | 626 Mio. | |
-46.63% | 617 Mio. |